JP2020532555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532555A5 JP2020532555A5 JP2020512813A JP2020512813A JP2020532555A5 JP 2020532555 A5 JP2020532555 A5 JP 2020532555A5 JP 2020512813 A JP2020512813 A JP 2020512813A JP 2020512813 A JP2020512813 A JP 2020512813A JP 2020532555 A5 JP2020532555 A5 JP 2020532555A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- neuroprotection
- following
- induced
- soman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010010904 Convulsion Diseases 0.000 description 3
- 230000004112 neuroprotection Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000005809 status epilepticus Diseases 0.000 description 2
- OZOMQRBLCMDCEG-CHHVJCJISA-N 1-[(z)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(O1)=CC=C1\C=N/N1C(=O)NC(=O)C1 OZOMQRBLCMDCEG-CHHVJCJISA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- GRXKLBBBQUKJJZ-UHFFFAOYSA-N Soman Chemical compound CC(C)(C)C(C)OP(C)(F)=O GRXKLBBBQUKJJZ-UHFFFAOYSA-N 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229960001987 dantrolene Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000036279 refractory period Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023010846A JP2023055802A (ja) | 2017-09-05 | 2023-01-27 | ダントロレンを使用して神経薬暴露を治療する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762554049P | 2017-09-05 | 2017-09-05 | |
| US62/554,049 | 2017-09-05 | ||
| US201862674406P | 2018-05-21 | 2018-05-21 | |
| US62/674,406 | 2018-05-21 | ||
| PCT/US2018/049515 WO2019050923A1 (en) | 2017-09-05 | 2018-09-05 | METHODS OF USING DANTROLENE TO TREAT EXPOSURE TO A NEUROTOXIC AGENT |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023010846A Division JP2023055802A (ja) | 2017-09-05 | 2023-01-27 | ダントロレンを使用して神経薬暴露を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020532555A JP2020532555A (ja) | 2020-11-12 |
| JP2020532555A5 true JP2020532555A5 (https=) | 2021-07-26 |
Family
ID=63708449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512813A Pending JP2020532555A (ja) | 2017-09-05 | 2018-09-05 | ダントロレンを使用して神経薬暴露を治療する方法 |
| JP2023010846A Pending JP2023055802A (ja) | 2017-09-05 | 2023-01-27 | ダントロレンを使用して神経薬暴露を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023010846A Pending JP2023055802A (ja) | 2017-09-05 | 2023-01-27 | ダントロレンを使用して神経薬暴露を治療する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20200383954A1 (https=) |
| EP (1) | EP3678659B1 (https=) |
| JP (2) | JP2020532555A (https=) |
| KR (1) | KR20200047655A (https=) |
| CN (1) | CN111093652A (https=) |
| AU (1) | AU2018328131B2 (https=) |
| BR (1) | BR112020004429A2 (https=) |
| CA (1) | CA3074732A1 (https=) |
| IL (1) | IL272847B1 (https=) |
| MA (1) | MA50080A (https=) |
| MX (2) | MX2020002485A (https=) |
| SG (1) | SG11202001749SA (https=) |
| UA (1) | UA126688C2 (https=) |
| WO (1) | WO2019050923A1 (https=) |
| ZA (1) | ZA202001258B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022538608A (ja) * | 2019-06-28 | 2022-09-05 | ザ トラスティーズ オヴ ザ ユニヴァーシティー オヴ ペンシルバニア | アルツハイマー病の治療のための鼻腔内ダントロレン投与 |
| WO2023081873A1 (en) * | 2021-11-05 | 2023-05-11 | Quorum Innovations, Llc | Materials and methods for preventing or reducing toxicity to organophosphates and other toxic materials |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7758890B2 (en) * | 2001-06-23 | 2010-07-20 | Lyotropic Therapeutics, Inc. | Treatment using dantrolene |
| EP1603513B1 (en) * | 2003-03-04 | 2020-12-30 | Lyotropic Therapeutics, Inc. | Dantrolene compositions |
| WO2013040501A1 (en) * | 2011-09-16 | 2013-03-21 | Pharmathene, Inc. | Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof |
| DK2925327T3 (da) * | 2012-11-30 | 2024-03-25 | Univ California | Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression |
-
2018
- 2018-09-05 UA UAA202002205A patent/UA126688C2/uk unknown
- 2018-09-05 BR BR112020004429-6A patent/BR112020004429A2/pt unknown
- 2018-09-05 JP JP2020512813A patent/JP2020532555A/ja active Pending
- 2018-09-05 MX MX2020002485A patent/MX2020002485A/es unknown
- 2018-09-05 US US16/644,281 patent/US20200383954A1/en not_active Abandoned
- 2018-09-05 WO PCT/US2018/049515 patent/WO2019050923A1/en not_active Ceased
- 2018-09-05 MA MA050080A patent/MA50080A/fr unknown
- 2018-09-05 KR KR1020207009450A patent/KR20200047655A/ko not_active Ceased
- 2018-09-05 EP EP18779490.4A patent/EP3678659B1/en active Active
- 2018-09-05 CA CA3074732A patent/CA3074732A1/en active Pending
- 2018-09-05 CN CN201880057290.XA patent/CN111093652A/zh active Pending
- 2018-09-05 AU AU2018328131A patent/AU2018328131B2/en active Active
- 2018-09-05 SG SG11202001749SA patent/SG11202001749SA/en unknown
-
2020
- 2020-02-23 IL IL272847A patent/IL272847B1/en unknown
- 2020-02-27 ZA ZA2020/01258A patent/ZA202001258B/en unknown
- 2020-03-04 MX MX2023012415A patent/MX2023012415A/es unknown
-
2021
- 2021-12-02 US US17/540,878 patent/US20220087980A1/en active Pending
-
2023
- 2023-01-27 JP JP2023010846A patent/JP2023055802A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hook et al. | Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders | |
| JP2020531121A5 (https=) | ||
| JP2020532555A5 (https=) | ||
| MA46585A (fr) | Méthodes de traitement de l'atrophie musculaire et des maladies osseuses faisant appel à de nouvelles protéines hybrides piégeant le ligand d'actriib | |
| HRP20210680T1 (hr) | POBOLJŠANA PROTUTIJELA KOJA VEŽU Aβ PROTOFIBRIL | |
| MA52631A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
| EP3762505A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT FOR PARKINSON'S DISEASE | |
| JPWO2019207359A5 (https=) | ||
| EP3737376A4 (en) | SELECTIVE HISTONE ACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASES | |
| EP3664795A4 (en) | CANNABIS AND DERIVATIVES THEREOF IN THE TREATMENT OF PAIN AND INFLAMMATION ASSOCIATED WITH DENTAL MARSH AND BONE REGENERATION ASSOCIATED WITH JAWBONE DEFECTS | |
| EP3813828A4 (en) | METHOD OF TREATMENT OF AGITATION WITH DEXMEDETOMIDIN HYDROCHLORIDE | |
| JP2016523963A5 (https=) | ||
| MA53739A (fr) | Composition et son utilisation pour le traitement de la maladie de parkinson et de troubles apparentés | |
| EP2342215A4 (en) | METHOD AND COMPOSITION FOR CHLAMYDIA ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DETECTION | |
| EP3823616A4 (en) | USE OF RILUZOLE PRODRUGS IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| IL311734A (en) | Methods and compositions for the treatment of polycystic kidney disease | |
| IL320898A (en) | Phthalazine-based modulators for the treatment of diseases | |
| MA55141A (fr) | Composés cyanoaryl-aniline pour le traitement d'affections de la peau | |
| EP3788052A4 (en) | ACYLPHOSPHONAMIDATE AND ACYLBENZYLAMINE AS ANTAGONISTS OF THE BCL FAMILY FOR THE CLINICAL MANAGEMENT OF CONDITIONS CAUSED OR MEDIATED BY SENESCENT CELLS AND TREATMENT OF CANCER | |
| EP3746016A4 (en) | BODY CARE INSTRUMENT FOR COOLING AND TREATING THE SKIN | |
| MA38697A1 (fr) | 4-(5-(4-chlorophényl)-2-(2-cyclopropylacétyl)-1,4-diméthyl-1h-pyrrol-3-yl)benzène-sulfonamide à titre de modulateur du nachr alpha 7 | |
| EP4228628A4 (en) | METALLOENZYME INHIBITORS FOR THE TREATMENT OF CANCER, ALZHEIMER'S DISEASE, HEMOCHROMATOSIS AND OTHER DISORDERS | |
| EP3852722A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE | |
| EP4196140A4 (en) | PLASMIDIC VECTORS AND NANOPARTICLES FOR TREATING EYE DISORDERS | |
| EP3920924A4 (en) | LOW-DOSE PRIDOIDIN FOR THE TREATMENT OF PARKINSON'S DISEASE AND OTHER PARKINSONIC-RELATED DISEASES |